2023
Emergency use of sugammadex after failure of standard reversal drugs and postoperative pulmonary complications: A retrospective cohort study
Bruceta M, Singh P, Bonavia A, Carr Z, Karamchandani K. Emergency use of sugammadex after failure of standard reversal drugs and postoperative pulmonary complications: A retrospective cohort study. Journal Of Anaesthesiology Clinical Pharmacology 2023, 39: 232-238. PMID: 37564851, PMCID: PMC10410049, DOI: 10.4103/joacp.joacp_289_21.Peer-Reviewed Original ResearchPostoperative pulmonary complicationsRetrospective cohort studyPulmonary complicationsNeuromuscular blockadeCohort studyReversal drugsMajor postoperative pulmonary complicationsTertiary care academic hospitalAdministration of neostigmineInpatient noncardiac surgeryNeostigmine/glycopyrrolateComposite primary outcomeUse of sugammadexComposite outcome measureNoncardiac surgeryAdult patientsPrimary outcomeGeneral anesthesiaProspective studyMedical recordsAcademic hospitalOutcome measuresSugammadexHigh incidenceComplications
2019
CHA2DS2-VASc Score and In-Hospital Mortality in Critically Ill Patients With New-Onset Atrial Fibrillation
Karamchandani K, Schoaps RS, Abendroth T, Carr ZJ, King TS, Bonavia A. CHA2DS2-VASc Score and In-Hospital Mortality in Critically Ill Patients With New-Onset Atrial Fibrillation. Journal Of Cardiothoracic And Vascular Anesthesia 2019, 34: 1165-1171. PMID: 31899140, DOI: 10.1053/j.jvca.2019.11.044.Peer-Reviewed Original ResearchConceptsNew-onset atrial fibrillationIntensive care unitTertiary care academic institutionHospital mortalityVASc scoreAtrial fibrillationIll patientsAdult patientsVascular diseasePrognostic markerTertiary care academic medical centerAssociation of CHAConcomitant vascular diseaseHospital mortality rateIn-Hospital MortalitySingle-center studyReliable prognostic markersAcademic medical centerElectronic medical recordsCHA2DS2-VAScHospital deathCare unitMedical recordsRetrospective analysisMedical CenterStroke prophylaxis in critically-ill patients with new-onset atrial fibrillation
Schoaps RS, Quintili A, Bonavia A, Carr ZJ, Lehman EB, Abendroth T, Karamchandani K. Stroke prophylaxis in critically-ill patients with new-onset atrial fibrillation. Journal Of Thrombosis And Thrombolysis 2019, 48: 394-399. PMID: 30963394, DOI: 10.1007/s11239-019-01854-5.Peer-Reviewed Original ResearchConceptsNew-onset atrial fibrillationCHA2DS2-VASc scoreOral anticoagulant therapyOral anticoagulantsIll patientsStroke prophylaxisAnticoagulant therapyHospital dischargeAtrial fibrillationEffective stroke prophylaxisOnset atrial fibrillationStroke/TIACongestive heart failureLong-term incidenceElectronic medical recordsEligible patientsICU survivorsAdult patientsHeart failureThromboembolic diseaseMedical recordsHigh incidencePatientsAnticoagulantsStudy period
2018
Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single-center retrospective analysis
Karamchandani K, Schoaps RS, Bonavia A, Prasad A, Quintili A, Lehman EB, Carr ZJ. Continuation of atypical antipsychotic medications in critically ill patients discharged from the hospital: a single-center retrospective analysis. Therapeutic Advances In Drug Safety 2018, 10: 2042098618809933. PMID: 31019677, PMCID: PMC6463330, DOI: 10.1177/2042098618809933.Peer-Reviewed Original ResearchIntensive care unitAtypical antipsychoticsHospital dischargeMale sexRisk factorsSingle-center retrospective chart analysisSingle-center retrospective analysisTertiary care academic medical centerAdult intensive care unitsRisk of continuationSignificant adverse eventsRetrospective chart analysisAssociated risk factorsIntensive care settingAtypical antipsychotic medicationsYears of ageAcademic medical centerLong-term riskLong-term useAAP therapyCause mortalityAdult patientsAdverse eventsOlder patientsICU patients